The Approval Process in Action

AI-Powered Medical Education Suite Cuts Costs, whilst Enhancing Clinical Skills Training for Future Doctors
Source: Streetwise Reports (06/16/2025)

Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) launched its enhanced medical education suite in Minnesota, showing strong reliability and providing schools with up to 40% cost savings. Read on to find out how AI-simulated patients are reshaping medical education and enhancing clinical skills at scale.

read more >

Orogen: End of Another Chapter Draws Near
Source: Adrian Day (06/16/2025)

Global Analyst Adrian Day discusses developments at some companies on his list, including Orogen Royalties Inc. (OGN:TSXV; OGNRF:OTCQX) and Franco-Nevada Corp. (FNV:TSX; FNV:NYSE).

read more >

Q1/25 Financials of Cancer Drug Developer Released
Source: Dr. Douglas Loe (06/12/2025)

Rakovina Therapeutics Inc.'s (RKV:TSX.V) CA$4 million equity offering is nearing completion, noted a Leede Financial Inc. report.

read more >

Analyst Likes Co. Developing Immuno-oncology Drugs
Source: Dr. Matthew Keller (06/10/2025)

There are multiple reasons to be bullish on this undervalued stock with significant potential upside, noted an H.C. Wainwright & Co. report.

read more >

New RA Drug Shown to Work, Be Safe
Source: Dr. Martin Fan (06/10/2025)

"Efficacy at six months represented a 'best case' scenario, in our view," and "safety was very favorable," noted a Wedbush report.

read more >